NIH-funded research R21 grant

Exploring ways to reverse aging at the cellular level

Official title: Understanding the cellular time machine that enables rejuvenation

Funded at University of California Los Angeles · NIH-11073849 · Data updated 2026-11-12

This study is exploring new ways to help older cells and tissues feel young again by using special proteins, which could improve how our organs work and even help reverse some effects of aging, with hopes of developing treatments for people as we all get older.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of California Los Angeles
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startDecember 15, 2024
Project endNovember 30, 2026
Funding year2025
Award (this year)$422,419
NIH project number1R21AG092008-01
Project IDNIH-11073849 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are older adults experiencing age-related health issues or decline in organ function.

Less likely to help

Patients who are not aged or do not exhibit age-related conditions may not benefit from this research.

What this research studies

This research investigates innovative methods to rejuvenate aging cells and tissues using specific transcription factors that can reset their epigenetic profiles. By employing techniques like in vivo cellular reprogramming, the study aims to enhance organ function and potentially reverse age-related decline. Initial experiments have shown promising results in aged mice, including improved muscle regeneration and better glucose tolerance. The goal is to translate these findings into potential therapies for humans as the aging population grows.

Why it matters

Potential benefit: If successful, this research could lead to groundbreaking treatments that significantly improve health and quality of life for older adults.

How similar studies have gone: Other research has shown success with similar cellular reprogramming approaches, indicating a promising avenue for rejuvenation therapies.

Where this research is happening

  • University of California Los Angeles
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Plath, Kathrin — University of California Los Angeles
  • Study coordinator: Plath, Kathrin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.